Synairgen reports preliminary findings from phase I trial of IFN-beta biomarker neopterin April 6, 2009
Neogenix to initiate clinical trial of monoclonal antibodies for colorectal and pancreatic cancer Dec. 15, 2008
Epigenomics presents update on PRESEPT clinical study of Septin 9 biomarker in colorectal cancer Oct. 28, 2008
FDA grants regulatory clearance to Response Biomedical to market Ramp NT-proBNP test for HF July 25, 2008
RSS